Brought to you by:
Survey of off-label treatment of complex repair pinpoints factors behind underreported outcomes data
The potential for cost and time to be key factors in low levels of outcomes data reporting emerged during a national survey of the off-label use of approved endovascular devices for complex aortic aneurysm repair. Grayson S. Pitcher, MD, an…
Societies seek consensus on NIVL management amid ‘paucity of rigorous data’
The diagnosis and management of non-thrombotic iliac vein lesions (NIVL) is the focus of a newly published set of consensus statements from the Vascular Interventional Advances (VIVA) Foundation, the American Venous Forum (AVF), and the American Vein and Lymphatic Society…
SVS urges revisions for independent cardiology certification board
The Society for Vascular Surgery (SVS) has expressed conditional support for cardiology establishing an independent certification board but objects to provisions in the current American Board of Cardiovascular Medicine (ABCVM) proposal as they conflict significantly with the mission and requirements…
Centerline Biomedical receives FDA 510(k) clearance for new IOPS Viewpoint catheter
Centerline Biomedical recently announced that its Intra-Operative Positioning System (IOPS) Viewpoint catheter has received Food and Drug Administration (FDA) 510(k) clearance. The Viewpoint catheter is the most recent addition to the company’s patented IOPS portfolio. A press release details that Viewpoint—a…
Vascular Therapies completes enrollment in the ACCESS 2 study
Vascular Therapies has today announced completion of enrollment in the ACCESS 2 trial, a Phase III prospective randomized, multicenter clinical study of Sirogen for the surgical creation of arteriovenous (AV) fistula in patients requiring hemodialysis vascular access. Vascular Therapies developed…
SVS History Work Group’s landmark project culminates in new book
The 2024 Vascular Annual Meeting (VAM) saw the culmination of a decade-long project by the Society for Vascular Surgery’s (SVS) History Project Work Group. The release of the book, Legends Leaders Pioneers: Surgeons Who Built Vascular Surgery, marks a significant…
Silk Road celebrates milestone of 100,000 TCAR procedures
Silk Road Medical has announced the milestone of more than 100,000 transcarotid artery revascularisation (TCAR) procedures having been performed to date. “A growing number of patients come to us looking for a solution that is minimally invasive and requires less…
CIRSE begins CALCIO trial enrolment for treatment of CLTI with Shockwave IVL system
The Cardiovascular and Interventional Society of Europe (CIRSE) have announced that patient enrolment for the CALCIO trial has begun. CALCIO started patient enrolment on 15 July, 2024, with the goal of recruiting 400 chronic limb-threatening ischaemia (CLTI) patients over the…
Thrombolex and Aidoc announce strategic partnership to advance breakthrough PE treatment
Thrombolex and Aidoc have announced a strategic partnership aimed at revolutionising the treatment of acute pulmonary embolism (PE), a press release reports. This strategic collaboration, the release details, will leverage Aidoc’s artificial intelligence (AI) technology to accelerate patient identification and…
CEA and TCAR should be ‘first-line’ interventions for weekend carotid revascularization, researchers advise
Patients who undergo carotid revascularization at the weekend have increased odds of complications and mortality, with transfemoral carotid artery stenting (TFCAS) posing the highest risk and transcarotid artery revascularization (TCAR) the lowest, compared to carotid endarterectomy (CEA). This is one…